Showing 121-130 of 1644 results for "".
Expert Opinion: Neuropsychological Impairments In Females with Primary Sjögren's Syndrome: New Insights
https://practicalneurology.com/columns/practice-management/expert-opinion-neuropsychological-impairments-in-females-with-primary-sjgrens-syndrome-new-insights/30854/The pSS literature has reported varying degrees of central nervous system involvement in individuals with this condition and secondary cognitive deficits associated with the disease.Concussions and the National Football League
https://practicalneurology.com/diseases-diagnoses/headache-pain/concussions-and-the-national-football-league/30595/As understanding of TBI deepens, professional sports associations are responding. An update on NFL policy allows an understanding of the intersection of research and real-life practice.- Getting a Grip on Vertigohttps://practicalneurology.com/columns/practice-management/getting-a-grip-on-vertigo/31435/Understanding Vertigo: Diagnosis and Management in Clinical NeurologyVertigo, a prevalent symptom in neurology, is characterized by the illusion of movement, typically rotational, resulting from imbalances in vestibular activity. Clinicians often associate vertigo with nystagmus, oscillopsia, postur
CIDP in an Adolescent After Pfizer-BioNTech COVID-19 Vaccination
https://practicalneurology.com/diseases-diagnoses/neuromuscular/cidp-in-an-adolescent-after-pfizer-biontech-covid-19-vaccination/32057/A case of pediatric CIDP temporally related to the Pfizer-BioNTech COVID-19 vaccine; more information is needed to leverage the vaccine-related risk with the risk associated with primary COVID-19.Challenge Case Report: Acute Onset of Expressive Aphasia, Visual Disturbances, and Severe Headache
https://practicalneurology.com/programs/practical-neurology/challenge-case-report-acute-onset-of-expressive-aphasia-visual-disturbances-and-severe-headache/33146/The differential diagnosis in the setting of leptomeningeal enhancement is broad, but when seen in association with an expansile intraparenchymal mass, there should be high suspicion for a neoplastic process.Hypermobility Spectrum Disorders and Migraine: Screening Matters
https://practicalneurology.com/diseases-diagnoses/headache-pain/hypermobility-spectrum-disorders-and-migraine-screening-matters/36118/This article reviews the association between hypermobility spectrum disorders and migraine, highlighting the importance of screening for these disorders in people with migraine to improve diagnosis, management, and outcomes.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31209/Cognitive and Behavioral Impacts of Antiepileptic Drugs in Epilepsy TreatmentAntiepileptic drugs (AEDs) are fundamental in managing epilepsy, yet their use is frequently associated with cognitive and behavioral side effects. The precise mechanisms underpinning these changes are not fully elucidated,
Biomarker Testing Modalities for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/biomarker-testing-modalities-for-alzheimer-disease/35432/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors physicians should consider when ordering a biomarker test and recommendations for how physicians should communicate the need for a particular test with their pThe Use of Intracranial Vessel Wall MRI for the Diagnosis of Vasculitis
https://practicalneurology.com/diseases-diagnoses/stroke/the-use-of-intracranial-vessel-wall-mri-for-the-diagnosis-of-vasculitis/37234/Jae W. Song, MD, MS, Associate Professor of Radiology at the University of Pennsylvania, Philadelphia, PA, discusses the diagnostic value of intracranial vessel wall MRI for vasculitis, as well as when clinicians should order this imaging technique and the challenges that may arise.- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31204/Summary of Recent Advances and Findings in NeurologyThe 2007 American Stroke Association’s International Stroke Conference in San Francisco highlighted critical barriers in stroke management and innovative therapeutic advancements. A significant finding revealed that approximately 50% of individuals